Share:
Peer-Reviewed Publication
Epilepsia2024;65(5):1451-1461.May 1, 2024Journal Article

Somatic variants as a cause of drug-resistant epilepsy including mesial temporal lobe epilepsy with hippocampal sclerosis.

Robert J Carton1,2, Michael G Doyle1,2,3,4, Hugh Kearney1,3, Charles A Steward5, Nicholas J Lench5, Anthony Rogers5, Erin L Heinzen6, Seamus McDonald2, Joanna Fay7, Austin Lacey1, Alan Beausang8, Jane Cryan8, Francesca Brett8, Hany El-Naggar1,3, Peter Widdess-Walsh1,3, Daniel Costello1,9, Ronan Kilbride1,3, Colin P Doherty1,10, Kieron J Sweeney1,3, Donncha F O'Brien1,3, David C Henshall1, Norman Delanty1,2,3, Gianpiero L Cavalleri1,2, Katherine A Benson1,2
1FutureNeuro Science Foundation Ireland Research Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.
2School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
3Epilepsy Programme, Department of Neurology, Beaumont Hospital, Dublin, Ireland.
4Strategic Academic Recruitment Doctor of Medicine Programme, Royal College of Surgeons in Ireland in collaboration with Blackrock Clinic, Dublin, Ireland.
5Congenica Limited, BioData Innovation Centre, Cambridge, UK.
6Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
7Royal College of Surgeons in Ireland Biobanking Service, Dublin, Ireland.
8Department of Neuropathology, Beaumont Hospital, Dublin, Ireland.
9Department of Neurology, Cork University Hospital, Cork, Ireland.
10Department of Neurology, St. James's Hospital, Dublin, Ireland.

Abstract

OBJECTIVE: The contribution of somatic variants to epilepsy has recently been demonstrated, particularly in the etiology of malformations of cortical development. The aim of this study was to determine the diagnostic yield of somatic variants in genes that have been previously associated with a somatic or germline epilepsy model, ascertained from resected brain tissue from patients with multidrug-…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.